Skip to main content
TipRanks
Go Ultimate75% OFF

Debra Odink Insider Profile

4 Followers

Debra Odink, CTO at Anthera Pharmaceuticals, holds 21.75K shares in Anthera Pharmaceuticals (Ticker: ANTH).

Debra Odink's Trading History

ANTH
Anthera Pharmaceuticals
Oct 13, 2015CTOUninformative Sell7.41K―
ANTH
Insider Shares: 21.75K (0.05%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 13, 2015Uninformative Sell$7.41K1,205$6.15―
Jan 02, 2015Uninformative Buy$0.001,364$0.00―
Jan 02, 2015Uninformative Sell$0.001,364$0.00―
Mar 27, 2014Uninformative Sell$9.18K2,783$3.30―
Mar 27, 2014Uninformative Sell$0.003,864$0.00―

You May Also Like

Debra Odink insider profile FAQ

What is the percentage of profitable transactions made by Debra Odink?
The percentage of profitable transactions made by Debra Odink is 50%.
What is the average return per transaction made by Debra Odink?
The average return per transaction made by Debra Odink is -23.30%.
What stocks does Debra Odink hold?
Debra Odink holds: ANTH stocks.
What was Debra Odink’s latest transaction?
Debra Odink’s latest transaction was an Uninformative Sell of $7.41K.
What was Debra Odink's most profitable transaction?
Debra Odink’s most profitable transaction was an Informative Buy of ANTH stock on September 24, 2010. The return on the trade was 16.10%.
What is Debra Odink's role in Anthera Pharmaceuticals?
Debra Odink's role in Anthera Pharmaceuticals is CTO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.